Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | March 12, 2020

Led Zeppelin Victorious at the Ninth Circuit

Blog | March 12, 2020

Massachusetts Patent Litigation Wrap Up — August 2019

Blog | March 05, 2020

EDTX Monthly Wrap-Up: February 2020

Blog | March 04, 2020

Legal Alert: EU Unified Patent Court and Unitary Patent Update

Blog | February 07, 2020

EDTX & NDTX Monthly Wrap-Up — January 2020

Blog | February 07, 2020

Increasing Competition in the Biologic Market Through Truthful Advertising

Blog | February 05, 2020

Patenting Software: A Case Study in Overcoming Alice

Blog | January 31, 2020

White Paper | Biosimilars - 2019 Year in Review

Article | January 30, 2020

Fish Attorneys Author Fourth Article of a Four-Part Series in Biosimilar Development, "Biosimilar Litigation Review: Anticompetitive Conduct Cases & Post-Grant Patent Challenges"

Article | January 27, 2020

Fish Attorneys Author Part Three of a Four-Part Series in Biosimilar Development, "Biosimilar Litigation Review: BPCIA Federal Circuit Appeals Pending & Recently Decided"

Article | January 21, 2020

Fish Attorneys Author Part Two of a Four-Part Series in Biosimilar Development, "Biosimilar Litigation Review: BPCIA Cases Settled Or Dismissed In 2019"

Q&A | January 21, 2020

Q&A with Kurt Glitzenstein for Corporate Counsel Business Journal, "Mastering the Art of Pricing in Complex Litigation"